Oramed Pharmaceuticals Inc
ORMP
|
|
| |
|
| Trading Volume | 958 |
|
|
3.58 - 1.71 |
| Market Cap Full | $ 96.8M |
Quarterly +
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Q1 | 1.2% | 26.8% | -81.9% | -37.8% |
| Q2 | - | -4.6% | 64.2% | -48.4% |
| Q3 | - | -6.3% | -27.1% | 41.5% |
| Q4 | - | 1.9% | -10.1% | 85.7% |
Monthly +
| J | F | M | A | M | J | J | A | S | O | N | D |
| 2025 | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| 1.2 | - | - | - | - | - | - | - | - | - | - | - |
| 2024 | |||||||||||
| 29.7 | 9.9 | -10.9 | -22.5 | -3.5 | 22.4 | -4.5 | -6.3 | - | - | - | 1.7 |
| 2023 | |||||||||||
| -83.5 | 5.5 | 3.8 | 4.1 | 78 | -11.4 | -5.3 | -3.2 | -20.4 | -29.9 | 21.3 | 4.1 |
| 2022 | |||||||||||
| -39.8 | 19.8 | -13.8 | -42.1 | -5.3 | -6 | 91.7 | -1.8 | -24.8 | 9.7 | 18.9 | 42.4 |
| 2021 | |||||||||||
| 71.2 | 22.7 | 14 | 4.9 | 8.1 | 16.2 | 6.1 | 38.7 | 13.6 | 4.7 | -22.8 | -21 |
| 2020 | |||||||||||
| -3.2 | -23.2 | -22.8 | 1.6 | 1.6 | 12.4 | 4 | -7.6 | -23 | -5.4 | 72.5 | -0.5 |
EPS
| 2023 | 2022 | 2021 | 2020 | |
|---|---|---|---|---|
| Q1 | -0.1 | -0.3 | -0.2 | -0.2 |
| Q2 | -0 | -0.3 | -0.2 | -0.1 |
| Q3 | -0.1 | -0.2 | -0.7 | -0.1 |
| Q4 | 0 | -0.2 | 0.2 | -0.2 |
| A | -0.19 | 0.9 | -0.8 | -0.6 |